| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |